Cheon HG - Search Results

1

Synthesis and pharmacological profile of 1-aryl-3-substituted pyrrolo[3,2-c]quinolines.

Yum EK, Kang SK, Kim SS, Choi JK, Cheon HG. Yum EK, et al. Among authors: cheon hg. Bioorg Med Chem Lett. 1999 Oct 4;9(19):2819-22. doi: 10.1016/s0960-894x(99)00496-5. Bioorg Med Chem Lett. 1999. PMID: 10522698

2

Pharmacological studies on the new quinoline derivative 1-(2-methylphenyl)-4-[(3-hydroxypropyl) amino]-6-trifluoromethoxy-2,3-dihydropyrrolo[3,2-c] quinoline with potent anti-ulcer effect.

Cheon HG, Kim HJ, Kim SS, Choi JK, Kong JY. Cheon HG, et al. Arzneimittelforschung. 1998 Dec;48(12):1168-71. Arzneimittelforschung. 1998. PMID: 9893932

3

Anti-ulcer activity of newly synthesized acylquinoline derivatives.

Cheon HG, Kim HJ, Mo HK, Shin E, Lee Y. Cheon HG, et al. Arch Pharm Res. 1999 Apr;22(2):137-42. doi: 10.1007/BF02976537. Arch Pharm Res. 1999. PMID: 10230503

4

Anti-ulcer activity of SKP-450, a novel potassium channel activator, in rats.

Cheon HG, Kim HJ, Mo HK, Yoo SE, Lee BH. Cheon HG, et al. Pharmacol Res. 1999 Sep;40(3):243-8. doi: 10.1006/phrs.1999.0512. Pharmacol Res. 1999. PMID: 10479468

5

Binding affinities of 3-(3-phenylisoxazol-5-yl)methylidene-1-azabicycles to acetylcholine receptors.

Choi KI, Cha JH, Cho YS, Pae AN, Jin C, Yook J, Cheon HG, Jeong D, Kong JY, Koh HY. Choi KI, et al. Among authors: cheon hg. Bioorg Med Chem Lett. 1999 Oct 4;9(19):2795-800. doi: 10.1016/s0960-894x(99)00477-1. Bioorg Med Chem Lett. 1999. PMID: 10522693

6

Pharmacological properties of the gastric H(+)/K(+) ATPase inhibitor, AU-461.

Cheon HG, Kim HJ, Mo HK, Lee BH, Choi J. Cheon HG, et al. Pharmacology. 2000 Apr;60(3):161-8. doi: 10.1159/000028361. Pharmacology. 2000. PMID: 10754453

7

Pharmacological properties of a newly synthesized H(+)/K(+) ATPase inhibitor, 1-(2-methyl-4-methoxyphenyl)-4-.

Cheon HG, Lee SS, Lim H, Lee DH. Cheon HG, et al. Eur J Pharmacol. 2001 Jan 5;411(1-2):187-192. doi: 10.1016/s0014-2999(00)00920-1. Eur J Pharmacol. 2001. PMID: 11137875

8

LC-MS/MS identification of in vitro metabolites of a new H+/K+ ATPase inhibitor, KR-60436 produced by rat and human liver microsomes.

Choi SJ, Ji HY, Baek SK, Lee HY, Choi JK, Cheon HG, Lee DH, Lim H, Lee HS. Choi SJ, et al. Among authors: cheon hg. J Pharm Biomed Anal. 2002 Jun 1;28(5):897-902. doi: 10.1016/s0731-7085(01)00696-3. J Pharm Biomed Anal. 2002. PMID: 12039631

9

Synthesis and PTP1B inhibition of 1,2-naphthoquinone derivatives as potent anti-diabetic agents.

Ahn JH, Cho SY, Ha JD, Chu SY, Jung SH, Jung YS, Baek JY, Choi IK, Shin EY, Kang SK, Kim SS, Cheon HG, Yang SD, Choi JK. Ahn JH, et al. Among authors: cheon hg. Bioorg Med Chem Lett. 2002 Aug 5;12(15):1941-6. doi: 10.1016/s0960-894x(02)00331-1. Bioorg Med Chem Lett. 2002. PMID: 12113814

10

Discovery of a novel protein tyrosine phosphatase-1B inhibitor, KR61639: potential development as an antihyperglycemic agent.

Cheon HG, Kim SM, Yang SD, Ha JD, Choi JK. Cheon HG, et al. Eur J Pharmacol. 2004 Feb 6;485(1-3):333-9. doi: 10.1016/j.ejphar.2003.11.070. Eur J Pharmacol. 2004. PMID: 14757158

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

98 results

Search Page

Filters